These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 2323731)

  • 21. MAO-A-induced mitogenic signaling is mediated by reactive oxygen species, MMP-2, and the sphingolipid pathway.
    Coatrieux C; Sanson M; Negre-Salvayre A; Parini A; Hannun Y; Itohara S; Salvayre R; Auge N
    Free Radic Biol Med; 2007 Jul; 43(1):80-9. PubMed ID: 17561096
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Potentiation of para-hydroxyamphetamine-induced head-twitch response by inhibition of monoamine oxidase type A in the brain.
    Tadano T; Satoh S; Satoh N; Kisara K; Arai Y; Kim SK; Kinemuchi H
    J Pharmacol Exp Ther; 1989 Jul; 250(1):254-60. PubMed ID: 2501477
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Potentiation of 3,4-methylenedioxymethamphetamine-induced 5-HT release in the rat substantia nigra by clorgyline, a monoamine oxidase A inhibitor.
    Hewton R; Salem A; Irvine RJ
    Clin Exp Pharmacol Physiol; 2007 Oct; 34(10):1051-7. PubMed ID: 17714093
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Substrate specificity of monoamine oxidase in pig liver mitochondria.
    Ekstedt B
    Med Biol; 1979 Aug; 57(4):220-3. PubMed ID: 513878
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Thyroid iodide transport is reduced by administration of monoamine oxidase A inhibitors to rats.
    Cabanillas AM; Masini-Repiso AM; Costamagna ME; Pellizas C; Coleoni AH
    J Endocrinol; 1994 Nov; 143(2):303-8. PubMed ID: 7829993
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Studies on beta-phenylethylamine deamination by human placental monoamine oxidase.
    Oguchi K; Kobayashi S; Uesato T; Kamijo K
    Jpn J Pharmacol; 1981 Feb; 31(1):7-14. PubMed ID: 6788990
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Specificity of endogenous substrates for types A and B monoamine oxidase in rat striatum.
    Schoepp DD; Azzaro AJ
    J Neurochem; 1981 Jun; 36(6):2025-31. PubMed ID: 6787175
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Oxidative stress by monoamine oxidase mediates receptor-independent cardiomyocyte apoptosis by serotonin and postischemic myocardial injury.
    Bianchi P; Kunduzova O; Masini E; Cambon C; Bani D; Raimondi L; Seguelas MH; Nistri S; Colucci W; Leducq N; Parini A
    Circulation; 2005 Nov; 112(21):3297-305. PubMed ID: 16286591
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cloning of a novel monoamine oxidase cDNA from trout liver.
    Chen K; Wu HF; Grimsby J; Shih JC
    Mol Pharmacol; 1994 Dec; 46(6):1226-33. PubMed ID: 7808446
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Effect of benzamide derivatives on rat brain monoamine oxidase activity in vitro].
    Gol'dina OA; Zagorevskiĭ VA; Lopatina KI; Sokolova TV; Gankina EM
    Biull Eksp Biol Med; 1986 Aug; 102(8):170-2. PubMed ID: 3742029
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Rat thyroid monoamine oxidase (MAO) is regulated by thyrotrophin: evidence that the main form of the enzyme (MAO-A) is not directly involved in iodide organification.
    Cabanillas AM; Masini-Repiso AM; Coleoni AH
    J Endocrinol; 1991 Oct; 131(1):25-31. PubMed ID: 1660515
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Some properties of monoamine oxidase in carp heart.
    Yamamoto M; Kobayashi S; Oguchi K
    Comp Biochem Physiol C Comp Pharmacol Toxicol; 1984; 78(1):117-22. PubMed ID: 6146456
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The effect of inhibitors of thyroid monoamine oxidase on the incorporation of iodine into thyroid slice protein.
    Huang CL; Schulz AR
    Life Sci II; 1972 Oct; 11(20):975-82. PubMed ID: 4662152
    [No Abstract]   [Full Text] [Related]  

  • 34. Therapeutic applications of selective and non-selective inhibitors of monoamine oxidase A and B that do not cause significant tyramine potentiation.
    Youdim MB; Weinstock M
    Neurotoxicology; 2004 Jan; 25(1-2):243-50. PubMed ID: 14697899
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Developmental changes in the activity and substrate specificities of mouse brain monoamine oxidase.
    Koide Y; Kobayashi K
    Neurochem Res; 1984 May; 9(5):595-606. PubMed ID: 6472564
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Psychomotor stimulant effects of beta-phenylethylamine in monkeys treated with MAO-B inhibitors.
    Bergman J; Yasar S; Winger G
    Psychopharmacology (Berl); 2001 Dec; 159(1):21-30. PubMed ID: 11797065
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Beta-phenylethylamine and benzylamine as substrates for human monoamine oxidase A: A source of some anomalies?
    Lewinsohn R; Glover V; Sandler M
    Biochem Pharmacol; 1980 Mar; 29(5):777-81. PubMed ID: 20227955
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Food constituents attenuate monoamine oxidase activity and peroxide levels in C6 astrocyte cells.
    Mazzio EA; Harris N; Soliman KF
    Planta Med; 1998 Oct; 64(7):603-6. PubMed ID: 9810264
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Substrate and inhibitor specificities for human monoamine oxidase A and B are influenced by a single amino acid.
    Geha RM; Rebrin I; Chen K; Shih JC
    J Biol Chem; 2001 Mar; 276(13):9877-82. PubMed ID: 11134050
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The properties of B-form monoamine oxidase in mitochondria from monkey platelet.
    Obata T; Aomine M
    Res Commun Mol Pathol Pharmacol; 2009-2010; 122-123():13-26. PubMed ID: 25022028
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.